A MECP2 missense mutation within the MBD domain in a Brazilian male with autistic disorder

Brain and Development

Volumn 33, Issue 10, 2011, Pages 807-809

  Campos, Mário ^a   Pestana, Cristiane Pinheiro ^a   dos Santos, Adriana Vaz ^a   Ponchel, Frederique ^b   Churchman, Sarah ^b   Abdalla Carvalho, Cláudia Bueno ^a   dos Santos, Jussara Mendonça ^a   dos Santos, Flavia Lima ^a   Gikovate, Carla Gruber ^c   Santos Rebouças, Cíntia Barros ^a   Pimentel, Márcia Mattos Gonçalves ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

DINUCLEOTIDE; METHYL CPG BINDING PROTEIN 2;

ADOLESCENT; AMINO ACID SEQUENCE; ARTICLE; AUTISM; BRAZIL; CHILD; COHORT ANALYSIS; CPG ISLAND; GENE DOSAGE; GENE REARRANGEMENT; GENETIC VARIABILITY; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PHENOTYPE; POINT MUTATION; PRESCHOOL CHILD; PROTEIN DOMAIN; RETT SYNDROME; SCHOOL CHILD; SEQUENCE ANALYSIS;

AUTISTIC DISORDER; BRAZIL; CHILD; CPG ISLANDS; DNA MUTATIONAL ANALYSIS; HUMANS; MALE; METHYL-CPG-BINDING PROTEIN 2; MUTATION, MISSENSE;

EID: 80755153712     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2011.04.015     Document Type: Article

References (15)

1. Levy S.E., Mandell D.S., Schultz R.T. Autism. Lancet 2009, 374:1627-1638.
2. O'Roak B.J., State M.W. Autism genetics: strategies, challenges, and opportunities. Autism Res 2008, 1:4-17.
3. Skuse D.H. Imprinting, the X-chromosome, and the male brain: explaining sex differences in the liability to autism. Pediatr Res 2000, 47:9-16.
4. Moretti P., Zoghbi H.Y. MeCP2 dysfunction in Rett syndrome and related disorders. Curr Opin Genet Dev 2006, 16:276-281.
5. Hite K.C., Adams V.H., Hansen J.C. Recent advances in MeCP2 structure and function. Biochem Cell Biol 2009, 87:219-227.
6. Carney R.M., Wolpert C.M., Ravan S.A., Shahbazian M., Ashley-Koch A., Cuccaro M.L., et al. Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatr Neurol 2003, 28:205-211.
7. Shibayama A., Cook E.H., Feng J., Glanzmann C., Yan J., Craddock N., et al. MECP2 structural and 3'-UTR variants in schizophrenia, autism and other psychiatric diseases: a possible association with autism. Am J Med Genet B Neuropsychiatr Genet 2004, 128B:50-53.
8. Coutinho A.M., Oliveira G., Katz C., Feng J., Yan J., Yang C., et al. MECP2 coding sequence and 3'UTR variation in 172 unrelated autistic patients. Am J Med Genet B Neuropsychiatr Genet 2007, 144B:475-483.
9. Campos M., Churchman S.M., Santos-Reboucas C.B., Ponchel F., Pimentel M.M. High frequency of nonrecurrent MECP2 duplications among Brazilian males with mental retardation. J Mol Neurosci 2010, 41:105-109.
10. Ramocki M.B., Peters S.U., Tavyev Y.J., Zhang F., Carvalho C.M., Schaaf C.P., et al. Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndrome. Ann Neurol 2009, 66:771-782.
11. Campos M., Abdalla C.B., Santos-Reboucas C.B., dos Santos A.V., Pestana C.P., Domingues M.L., et al. Low significance of MECP2 mutations as a cause of mental retardation in Brazilian males. Brain Dev 2007, 29:293-297.
12. Christodoulou J., Grimm A., Maher T., Bennetts B. RettBASE: the IRSA MECP2 variation database-a new mutation database in evolution. Hum Mutat 2003, 21:466-472.
13. Ravn K., Nielsen J.B., Uldall P., Hansen F.J., Schwartz M. No correlation between phenotype and genotype in boys with a truncating MECP2 mutation. J Med Genet 2003, 40:e5.
14. Yusufzai T.M., Wolffe A.P. Functional consequences of Rett syndrome mutations on human MeCP2. Nucleic Acids Res 2000, 28:4172-4179.
15. Ho K.L., McNae I.W., Schmiedeberg L., Klose R.J., Bird A.P., Walkinshaw M.D. MeCP2 binding to DNA depends upon hydration at methyl-CpG. Mol Cell 2008, 29:525-531.